Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,295 | 604 | 92.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $750.00 | 1 | 7.4% |
| Education | $25.66 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,858 | 245 | $0 (2024) |
| ABBVIE INC. | $2,773 | 81 | $0 (2024) |
| Lilly USA, LLC | $787.28 | 43 | $0 (2024) |
| UCB, Inc. | $465.46 | 26 | $0 (2024) |
| PFIZER INC. | $444.90 | 45 | $0 (2024) |
| Genentech USA, Inc. | $419.00 | 30 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $373.30 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $300.86 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $296.79 | 12 | $0 (2024) |
| Horizon Therapeutics plc | $271.80 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,028 | 96 | ABBVIE INC. ($660.09) |
| 2023 | $1,494 | 72 | AbbVie Inc. ($404.07) |
| 2022 | $1,013 | 57 | ABBVIE INC. ($332.26) |
| 2021 | $383.78 | 32 | Amgen Inc. ($323.34) |
| 2020 | $475.93 | 38 | Amgen Inc. ($207.79) |
| 2019 | $2,553 | 191 | Amgen Inc. ($609.70) |
| 2018 | $856.89 | 77 | Amgen Inc. ($450.57) |
| 2017 | $1,267 | 45 | AbbVie, Inc. ($874.93) |
All Payment Transactions
608 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Immunology | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Not Applicable | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 3,023 | 18,080 | $1.5M | $543,193 |
| 2022 | 40 | 3,378 | 12,981 | $1.0M | $351,516 |
| 2021 | 41 | 3,196 | 15,324 | $1.6M | $627,046 |
| 2020 | 30 | 1,947 | 6,996 | $674,308 | $225,892 |
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 12 | 6,875 | $570,625 | $231,911 | 40.6% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 17 | 4,030 | $362,700 | $104,147 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 404 | 663 | $139,230 | $58,625 | 42.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 184 | 253 | $69,828 | $31,746 | 45.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,680 | $57,120 | $29,816 | 52.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 46 | 207 | $109,650 | $21,265 | 19.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 113 | 113 | $49,042 | $17,693 | 36.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 261 | 508 | $14,224 | $5,223 | 36.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 92 | $14,260 | $4,757 | 33.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 331 | 511 | $5,966 | $4,229 | 70.9% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 31 | 217 | $6,944 | $3,813 | 54.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 255 | 487 | $7,668 | $3,681 | 48.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 29 | 152 | $9,985 | $3,334 | 33.4% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 339 | 622 | $9,330 | $3,133 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,984 | $2,237 | 37.4% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 37 | 71 | $4,896 | $2,130 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 37 | $5,365 | $2,089 | 38.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 149 | $8,493 | $1,650 | 19.4% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 335 | 616 | $4,312 | $1,619 | 37.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $2,420 | $1,582 | 65.4% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 45 | 104 | $2,556 | $1,151 | 45.0% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 43 | 86 | $1,720 | $971.80 | 56.5% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 19 | 34 | $2,264 | $947.24 | 41.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 15 | $2,341 | $898.50 | 38.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 28 | 30 | $1,502 | $870.30 | 57.9% |
About Dr. Michael Coan, D.O
Dr. Michael Coan, D.O is a Rheumatology healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1386955904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Coan, D.O has received a total of $10,071 in payments from pharmaceutical and medical device companies, with $2,028 received in 2024. These payments were reported across 608 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($9,295).
As a Medicare-enrolled provider, Coan has provided services to 11,544 Medicare beneficiaries, totaling 53,381 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Spokane, WA
- Active Since 06/29/2010
- Last Updated 03/25/2020
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1386955904
Products in Payments
- Enbrel (Biological) $2,242
- RINVOQ (Biological) $1,227
- TALTZ (Drug) $787.28
- Rituxan (Biological) $419.00
- XELJANZ (Drug) $407.34
- Cimzia (Drug) $406.68
- Humira (Biological) $344.88
- KRYSTEXXA (Biological) $304.52
- SAPHNELO (Biological) $300.86
- BENLYSTA (Biological) $296.79
- COSENTYX (Biological) $250.84
- SKYRIZI (Biological) $182.68
- EVENITY (Biological) $169.04
- TREMFYA (Drug) $161.58
- TAVNEOS (Drug) $123.47
- KEVZARA (Biological) $108.47
- KRYSTEXXA (Drug) $105.96
- Arcalyst (Drug) $97.24
- AVSOLA (Biological) $94.31
- Rinvoq (Biological) $93.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Spokane
Eric Mueller, M.d, M.D
Rheumatology — Payments: $66,481
Dr. Rebecca Muntean, M.d, M.D
Rheumatology — Payments: $24,156
Dr. Sean Lasalle, Md, MD
Rheumatology — Payments: $9,964
Penny Sczenski, Agpcnp-Bc, AGPCNP-BC
Rheumatology — Payments: $2,792
Catherine Lee, Md, MD
Rheumatology — Payments: $1,457
Lauren Johnson, M.d, M.D
Rheumatology — Payments: $383.30